Key statistics
On Friday, Lisata Therapeutics Inc (8NE:MUN) closed at 2.74, -17.96% below its 52-week high of 3.34, set on Jun 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.74 |
---|---|
High | 2.74 |
Low | 2.74 |
Bid | 2.70 |
Offer | 2.74 |
Previous close | 2.74 |
Average volume | 0.00 |
---|---|
Shares outstanding | 8.32m |
Free float | 6.73m |
P/E (TTM) | -- |
Market cap | 24.21m USD |
EPS (TTM) | -2.56 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 07:04 GMT.
More ▼
Announcements
- Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration
- Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024
- Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events
- Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis
- Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor Events
- Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER Trial
- Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor Events
- Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma
- Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on Monday, August 12, 2024
More ▼